Wilfried Ernst Erich Eberhardt

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315).

|Sep 25, 2024
Oligometastatic non-small cell lung cancer: Impact of local and contemporary systemic treatment approaches on clinical outcome.

Marcel Wiesweg, Claudia Küter, Johannes Schnorbach

|Aug 29, 2024
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE).

Christina Schulte, Thomas Gauler, Christoph Pöttgen

|Aug 09, 2021
Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment.

Georgios Stamatis, Stefanie Müller, Gerhard Weinreich

Pageof 1

Frequent Collaborators

2 joint publications

Michael Thomas

1 joint publications

Martin Stuschke

1 joint publications

Andreas Gröschel

1 joint publications

Martin Sebastian